Keyphrases
Multiple Sclerosis Treatment
100%
Interferon-β (IFN-β)
100%
In Vivo Response
100%
Neutralizing Antibodies
100%
Interferon-α (IFN-α)
100%
Biological Response
20%
After Injection
13%
Gene Expression
6%
Therapeutic Potential
6%
Interleukin-10
6%
ClinicalTrials.gov
6%
Phase II Study
6%
Gene number
6%
Relapsing-remitting multiple Sclerosis
6%
Bioactivity
6%
Interferon-β Treatment
6%
Myxovirus Resistance Protein A
6%
Blood Cells
6%
Therapeutic Benefits
6%
Immune-related Genes
6%
TNFSF10
6%
In Vivo Induction
6%
IFI27
6%
Inducible Genes
6%
Neuroscience
In Vivo
100%
Multiple Sclerosis
100%
Beta Interferon
100%
Neutralizing Antibody
100%
Interferon Alfa
100%
Gene Expression
6%
Relapsing Remitting Multiple Sclerosis
6%
Hemocyte
6%
Treatment of Multiple Sclerosis
6%
Myxovirus Resistance Protein A
6%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
Beta Interferon
100%
Neutralizing Antibody
100%
Alpha Interferon
100%
Myxovirus Resistance Protein A
6%